NGL Fine Chem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE887E01022
  • NSEID: NGLFINE
  • BSEID: 524774
INR
2,777.95
69.4 (2.56%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 11.64 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Fredun Pharma
Venus Remedies
Syncom Formul.
Kopran
NGL Fine Chem
Windlas Biotech
Jagsonpal Pharma
Hester Bios
Fermenta Biotec.
Amrutanjan Healt
Accent Microcell

Why is NGL Fine Chem Ltd ?

1
Company has a Debt to Equity ratio (avg) of 0.05 times
2
Poor long term growth as Operating profit has grown by an annual rate -4.18% of over the last 5 years
3
With a growth in Net Profit of 99.13%, the company declared Very Positive results in Jun 26
  • The company has declared positive results for the last 3 consecutive quarters
  • NET SALES(Q) At Rs 139.16 cr has Grown at 33.56%
  • PBDIT(Q) Highest at Rs 23.28 cr.
  • PBT LESS OI(Q) Highest at Rs 17.05 cr.
4
With ROCE of 13.3, it has a Expensive valuation with a 4.5 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 104.04%, its profits have risen by 174.1% ; the PEG ratio of the company is 0.2
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to NGL Fine Chem should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is NGL Fine Chem for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
NGL Fine Chem
104.04%
1.75
59.58%
Sensex
-10.5%
-0.78
13.50%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
13.18%
EBIT Growth (5y)
-4.18%
EBIT to Interest (avg)
18.27
Debt to EBITDA (avg)
1.05
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
1.18
Tax Ratio
24.67%
Dividend Payout Ratio
5.12%
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
17.47%
ROE (avg)
14.34%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
30
Industry P/E
37
Price to Book Value
5.22
EV to EBIT
28.01
EV to EBITDA
21.17
EV to Capital Employed
4.53
EV to Sales
3.32
PEG Ratio
0.17
Dividend Yield
0.06%
ROCE (Latest)
13.29%
ROE (Latest)
14.59%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company
NET SALES(Q)

At Rs 139.16 cr has Grown at 33.56%

PBDIT(Q)

Highest at Rs 23.28 cr.

PBT LESS OI(Q)

Highest at Rs 17.05 cr.

PAT(Q)

Highest at Rs 18.40 cr.

EPS(Q)

Highest at Rs 29.77

-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for NGL Fine Chem

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 17.05 cr has Grown at 210.56%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 18.40 cr has Grown at 99.1%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 139.16 cr has Grown at 33.56%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 23.28 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 17.05 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 18.40 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 29.77
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for NGL Fine Chem

Non Operating Income - Quarterly
Highest at Rs 7.43 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income